HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiang-Min Xie Selected Research

piclamilast

3/2019Anti‑inflammatory effect of ciclamilast in an allergic model involving the expression of PDE4B.
10/2006Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiang-Min Xie Research Topics

Disease

21Inflammation (Inflammations)
01/2021 - 03/2002
13Asthma (Bronchial Asthma)
02/2020 - 03/2002
11Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 12/2002
8Respiratory Hypersensitivity
04/2019 - 10/2006
5Airway Remodeling
02/2020 - 03/2011
5Edema (Dropsy)
10/2011 - 03/2002
4Hyperplasia
03/2019 - 10/2006
4Pneumonia (Pneumonitis)
05/2015 - 03/2007
3Cough
03/2021 - 01/2002
3Lung Neoplasms (Lung Cancer)
06/2020 - 08/2013
3Hypersensitivity (Allergy)
04/2019 - 02/2012
3Neoplasms (Cancer)
01/2018 - 08/2013
2Metaplasia
02/2020 - 01/2020
2Fibrosis (Cirrhosis)
05/2017 - 01/2017
2Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2017 - 01/2017
2Body Weight (Weight, Body)
01/2017 - 08/2013
2Lung Injury
01/2017 - 07/2011
2Lung Diseases (Lung Disease)
05/2015 - 12/2002
2Acute Lung Injury
01/2013 - 10/2011
2Allergic Rhinitis
02/2012 - 10/2006
1Virus Diseases (Viral Diseases)
01/2021
1Experimental Arthritis
05/2020
1Rheumatoid Arthritis
05/2020
1Hyperlipidemias (Hyperlipidemia)
08/2015
1Atherosclerosis
08/2015
1Eosinophilia
02/2012

Drug/Important Bio-Agent (IBA)

8SmokeIBA
01/2021 - 09/2012
7Messenger RNA (mRNA)IBA
01/2021 - 10/2006
7CytokinesIBA
01/2021 - 03/2002
7OvalbuminIBA
04/2019 - 03/2002
6AntigensIBA
01/2020 - 03/2002
5LipopolysaccharidesIBA
01/2017 - 03/2007
5Methacholine Chloride (Methacholine)FDA Link
08/2011 - 10/2006
4Pharmaceutical PreparationsIBA
01/2021 - 12/2002
4Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2011
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2011 - 07/2004
3CollagenIBA
02/2020 - 05/2017
3InterleukinsIBA
02/2020 - 01/2017
3Epoxide HydrolasesIBA
02/2020 - 01/2017
3bencycloquidium bromideIBA
05/2015 - 03/2011
3Peroxidase (Myeloperoxidase)IBA
10/2011 - 02/2009
3Leukotriene B4IBA
04/2010 - 10/2003
3AerosolsIBA
10/2003 - 01/2002
2Cadherins (E-Cadherin)IBA
01/2021 - 02/2020
2Cytochrome P-450 CYP2J2 (CYP2J2)IBA
02/2020 - 01/2020
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
02/2020 - 01/2020
2Indicators and Reagents (Reagents)IBA
02/2020 - 01/2020
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2020 - 01/2017
2Interleukin-17 (Interleukin 17)IBA
02/2020 - 01/2020
2Arachidonic Acid (Vitamin F)IBA
02/2020 - 01/2020
2Interleukin-4 (Interleukin 4)IBA
04/2019 - 10/2006
2piclamilastIBA
03/2019 - 10/2006
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
03/2019 - 05/2006
2Phosphodiesterase 4 InhibitorsIBA
03/2019 - 10/2006
2Bleomycin (Blenoxane)FDA LinkGeneric
05/2017 - 01/2017
2PolyphenolsIBA
08/2015 - 01/2013
2p38 Mitogen-Activated Protein KinasesIBA
08/2013 - 01/2013
2Polysaccharides (Glycans)IBA
10/2011 - 10/2006
2Biomarkers (Surrogate Marker)IBA
08/2011 - 03/2011
1Capsaicin (Zostrix)FDA Link
03/2021
1Poly I-CIBA
01/2021
1Chemotactic FactorsIBA
01/2021
1LigandsIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1cedrolIBA
05/2020
1Dinoprostone (PGE2)FDA Link
05/2020
114,15-epoxy-5,8,11-eicosatrienoic acidIBA
02/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2020
1Phosphotransferases (Kinase)IBA
02/2020
1Protein Kinases (Protein Kinase)IBA
02/2020
1Mitogen-Activated Protein KinasesIBA
01/2020
1AcidsIBA
01/2020
1Leukotriene D4IBA
04/2019
1Interleukin-5 (Interleukin 5)IBA
04/2019
1FlavonesIBA
04/2019
1Immunoglobulin E (IgE)IBA
04/2019
1N- (3,5- dichloro- 4- pyrid- 4- yl)- 3- cyclopentyl- oxy- 4- methylbenzamideIBA
03/2019
1salvianolic acid BIBA
04/2018
1Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA
04/2018
1MucinsIBA
04/2018
1MK 2206IBA
01/2018
1Matrix Metalloproteinases (MMPs)IBA
05/2017
1Grape Seed ExtractIBA
05/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1Apolipoproteins E (ApoE)IBA
08/2015
1GinsenosidesIBA
08/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013
1Protein Tyrosine PhosphatasesIBA
09/2012
1Interleukin-8 (Interleukin 8)IBA
09/2012
1EnzymesIBA
09/2012
1Protective AgentsIBA
08/2012
1AllergensIBA
02/2012
1Toll-Like Receptor 2IBA
10/2011
1IsoflavonesIBA
08/2011

Therapy/Procedure

4Oral Administration
03/2019 - 08/2011
3Therapeutics
05/2015 - 03/2011
2Drug Therapy (Chemotherapy)
01/2017 - 01/2013